Alcohol septal ablation in hypertrophic cardiomyopathy: an opportunity to be taken.
نویسندگان
چکیده
Since the first procedure performed by Sigwart at the Royal Brompton Hospital of London in 1994, alcohol septal ablation (ASA) has become a highly popular technique for the treatment of obstruction in hypertrophic cardiomyopathy (HCM). Percutaneous procedures have revolutionized the treatment of ischemic heart disease and arrhythmias and, more recently, there has been a great upsurge in their use in the treatment of structural heart disease and valve diseases. In recent years, the number of ASA procedures performed is in the region of 5to 10-fold higher than the number of myectomies. As Maron et al. report in a recent article, myectomy has largely been replaced by ASA in some European countries. This circumstance has led to the demise of myectomy programs in many centers. Myectomy continues to be the technique of choice in countries like the United States, perhaps the United Kingdom, and Italy. It may be that the characteristics of the public health systems of certain countries favor the development of percutaneous techniques and make it difficult for referral centers with surgical experience to continue their former activity. There are differences in the procedures, the complications, and the results associated with the two options that should be considered when choosing the most appropriate treatment for a given patient. It is important that the decision-making be shared among experienced professionals in units specialized in cardiomyopathies, with integrated programs for the invasive treatment of obstruction in HCM.
منابع مشابه
گزارش یک مورد Percutaneous Transluminal Septal Myocardial Ablation در کاردیومیوپاتی هیپرتروفیک
A number of patients with severe obstruction due to hypertrophic cardiomyopathy have derived benefit at least over the short-term from inventional infarction of a portion of the interventricular septum by the infusion of alcohol into a selectively catheterized septal artery , with reduction of the outflow gradient and improvement in symptoms . This paper contains success...
متن کاملLetter by ElBardissi regarding article, "Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy".
BACKGROUND The clinical efficacy of alcohol septal ablation for drug-refractory hypertrophic cardiomyopathy remains unclear. This study examines the outcome of alcohol septal ablation performed at a tertiary hypertrophic cardiomyopathy referral center. METHODS AND RESULTS Among 601 patients with severely symptomatic obstructive hypertrophic cardiomyopathy referred for alcohol septal ablation ...
متن کاملAlcohol septal ablation for obstructive hypertrophic cardiomyopathy.
Treatment of obstructive hypertrophic cardiomyopathy remains challenging. Medical therapy, surgical therapy, and pacemaker therapy have been shown to be beneficial in some patients over the years. Alcohol septal ablation is a catheter-based intervention that causes a controlled infarct in the septum leading to a decrease in the left ventricular outflow tract obstruction. Along with the impressi...
متن کاملHow Symptomatic Should a Hypertrophic Obstructive Cardiomyopathy Patient Be to Consider Alcohol Septal Ablation?
Outcome of Alcohol Septal Ablation in Mildly Symptomatic Patients With Hypertrophic Obstructive Cardiomyopathy: A Long-Term Follow-Up Study Based on the Euro-Alcohol Septal Ablation Registry Josef Veselka, Lothar Faber, Max Liebregts, Robert Cooper, Jaroslav Januska, Jan Krejci, Thomas Bartel, Maciej Dabrowski, Peter Riis Hansen, Vibeke Marie Almaas, Hubert Seggewiss, Dieter Horstkotte, Radka A...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Revista espanola de cardiologia
دوره 65 4 شماره
صفحات -
تاریخ انتشار 2012